FLPUTNAM INVESTMENT MANAGEMENT CO has added 95,234 shares of $BSX to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BSX.
BOSTON SCIENTIFIC Hedge Fund Activity
We have seen 871 institutional investors add shares of BOSTON SCIENTIFIC stock to their portfolio, and 656 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 5,862,792 shares (-18.6%) from their portfolio in Q2 2025, for an estimated $629,722,488
- BLACKROCK, INC. added 5,016,674 shares (+3.5%) to their portfolio in Q2 2025, for an estimated $538,840,954
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 4,568,703 shares (-20.5%) from their portfolio in Q1 2025, for an estimated $460,890,758
- BANK OF AMERICA CORP /DE/ added 4,078,325 shares (+14.8%) to their portfolio in Q1 2025, for an estimated $411,421,426
- FMR LLC removed 3,845,669 shares (-2.9%) from their portfolio in Q1 2025, for an estimated $387,951,088
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 3,662,461 shares (-22.2%) from their portfolio in Q2 2025, for an estimated $393,384,936
- TWO SIGMA ADVISERS, LP added 3,450,700 shares (+456.9%) to their portfolio in Q1 2025, for an estimated $348,106,616
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BOSTON SCIENTIFIC Insider Trading Activity
BOSTON SCIENTIFIC insiders have traded $BSX stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:
- MICHAEL F MAHONEY (Chairman, President & CEO) has made 0 purchases and 5 sales selling 493,328 shares for an estimated $50,348,180.
- JOSEPH MICHAEL FITZGERALD (EVP & Group Pres, Cardiology) has made 0 purchases and 3 sales selling 156,372 shares for an estimated $16,379,615.
- DANIEL J. BRENNAN (EVP and CFO) has made 0 purchases and 4 sales selling 99,950 shares for an estimated $10,504,430.
- ARTHUR C BUTCHER (EVP& Grp Pres, MedSurg & APAC) has made 0 purchases and 2 sales selling 34,627 shares for an estimated $3,578,501.
- JEFFREY B. MIRVISS (EVP&Pres, Periph Intervent) has made 0 purchases and 4 sales selling 21,895 shares for an estimated $2,294,072.
- EDWARD J LUDWIG has made 0 purchases and 3 sales selling 20,000 shares for an estimated $2,108,303.
- VANCE R BROWN (SVP, GC and Corp. Secretary) has made 0 purchases and 4 sales selling 19,304 shares for an estimated $1,964,182.
- JOHN BRADLEY SORENSON (EVP, Global Operations) has made 0 purchases and 5 sales selling 18,122 shares for an estimated $1,901,745.
- ELLEN M ZANE sold 13,586 shares for an estimated $1,416,133
- EMILY WOODWORTH (SVP, Global Controller and CAO) sold 9,887 shares for an estimated $999,872
- YOSHIAKI FUJIMORI sold 2,901 shares for an estimated $310,377
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BOSTON SCIENTIFIC Government Contracts
We have seen $26,645,751 of award payments to $BSX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION: $1,200,000
- Y90 GLASS MICROSPHERES: $1,197,000
- THERASPHERE Y-90: $963,835
- YTTRIUM-90 GLASS MICROSPHERE: $907,100
- THERASPHERE YTTIRUM-90 (Y-90) GLASS MICROSPHERES: $880,560
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BOSTON SCIENTIFIC Congressional Stock Trading
Members of Congress have traded $BSX stock 10 times in the past 6 months. Of those trades, 2 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 6 times. They made 0 purchases and 6 sales worth up to $90,000 on 06/26, 06/11, 05/13, 04/28, 03/17, 02/24.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 02/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BOSTON SCIENTIFIC Analyst Ratings
Wall Street analysts have issued reports on $BSX in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 07/24/2025
- Truist Securities issued a "Buy" rating on 07/24/2025
- Barclays issued a "Overweight" rating on 07/24/2025
- Baird issued a "Outperform" rating on 07/24/2025
- Raymond James issued a "Strong Buy" rating on 07/24/2025
- UBS issued a "Buy" rating on 07/24/2025
- Leerink Partners issued a "Outperform" rating on 06/16/2025
To track analyst ratings and price targets for BOSTON SCIENTIFIC, check out Quiver Quantitative's $BSX forecast page.
BOSTON SCIENTIFIC Price Targets
Multiple analysts have issued price targets for $BSX recently. We have seen 13 analysts offer price targets for $BSX in the last 6 months, with a median target of $124.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $125.0 on 07/24/2025
- David Rescott from Baird set a target price of $123.0 on 07/24/2025
- Larry Biegelsen from Wells Fargo set a target price of $124.0 on 07/24/2025
- Steven Lichtman from Oppenheimer set a target price of $118.0 on 07/24/2025
- Jayson Bedford from Raymond James set a target price of $124.0 on 07/24/2025
- Danielle Antalffy from UBS set a target price of $135.0 on 07/24/2025
- Matt Miksic from Barclays set a target price of $133.0 on 07/24/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BSX ticker page for more data.
